CA
SPPI

Continuum Advisory’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Continuum Advisory’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,550
Closed -$38K – 319
2021
Q3 		$38K Hold
17,550
– – 0.01% 288
2021
Q2 		$66K Buy
+17,550
New +$61K 0.02% 266

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Continuum Advisory's SPPI Position: Q4 2021 in Review

Continuum Advisory sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 17,550 shares — an estimated $38K sold.

Continuum Advisory first reported a position in SPPI in Q2 2021 and held it in 2 quarters. The position peaked at $66K in Q2 2021. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

  • Continuum Advisory reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Continuum Advisory sold 17,550 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $38K.
  • Continuum Advisory first reported a position in Spectrum Pharmaceuticals Inc in Q2 2021 and held it in 2 quarters.
  • Continuum Advisory's Spectrum Pharmaceuticals Inc position peaked at $66K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on Continuum Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.